Stay updated with breaking news from Panorama Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous09.01.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Provides Year-End Corporate Review 2023 European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Co...
Mainz Biomed Provides Year-End Corporate Review 2023...
Former Natera Manager will oversee all aspects of sales and support in EMEA, ensuring the continued commercialization of ColoAlert® across the region BERKELEY, Calif. and MAINZ, Germany, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is proud to announce the appointment of Tarrin Khairi-Taraki as Vice President of Commercial Operations, EMEA. Tarrin will pl
The fertility clinic in New York even tried to cover up the mistake, but the couple from Massachusetts filed a lawsuit and demanded to know what happened to their embryo.